[1]田　伟　李　峰　张　彬.STRAP在人脑胶质瘤组织中的表达及临床意义[J].中国临床神经外科杂志,2020,(08):510-512.[doi:10.13798/j.issn.1009-153X.2020.08.005]
　TIAN Wei,LI Feng,ZHANG Bin..Expression of serine threonine kinase receptor associated protein in human glioma tissues and its clinical significance[J].,2020,(08):510-512.[doi:10.13798/j.issn.1009-153X.2020.08.005]
点击复制

STRAP在人脑胶质瘤组织中的表达及临床意义()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2020年08期
页码:
510-512
栏目:
论著
出版日期:
2020-08-25

文章信息/Info

Title:
Expression of serine threonine kinase receptor associated protein in human glioma tissues and its clinical significance
文章编号:
1009-153X（2020）08-0510-03
作者:
田　伟　李　峰　张　彬
712000 陕西，陕西省核工业二一五医院病理科（田　伟），神经外科（李　峰、张　彬）
Author(s):
TIAN Wei1;  LI Feng2;  ZHANG Bin2.
1. Department of Pathology, Nuclear Industry 215 Hospital of Shaanxi, Xianyang 712000, China; 2.Department of Neurosurgery, Nuclear Industry 215 Hospital of Shaanxi, Xianyang 712000, China
关键词:
胶质瘤; 丝氨酸-苏氨酸激酶受体相关蛋白; 基因表达; 预后
Keywords:
Glioma;  Serine threonine kinase receptor associated protein;  Prognosis
分类号:
A
DOI:
10.13798/j.issn.1009-153X.2020.08.005
文献标志码:
R 739.41; Q 786
摘要:
目的 探讨人脑胶质瘤组织丝氨酸-苏氨酸激酶受体相关蛋白（STRAP）的表达变化及临床意义。方法 选取2013年6月至2016年9月手术切除的胶质瘤组织160例，术前均未接受过放化疗或免疫治疗；另选取2018年6月~2019年3月颅脑损伤内减压术中切除的正常脑组织40例为对照。采用免疫组化法检测STRAP的表达水平。随访时间截止至2018年10月，采用多因素Cox比例回归风险模型分析胶质瘤病人生存期的影响因素。结果 胶质瘤组织STRAP表达水平明显高于正常脑组织（P<0.05），而且随胶质瘤分级增高，STRAP表达水平明显增高（P<0.05）。160例随访3~60个月，随访期间死亡48例，复发98例。OS在3~58个月，中位OS为43个月（四分间距在36~51个月）。PFS在2~60个月，中位PFS为32个月（四分间距在18~40个月）。多因素Cox比例回归风险模型分析显示，年龄≥55岁、术前KPS评分<80分、WHO分级为Ⅲ~Ⅳ级、STRAP高表达是胶质瘤病人无进展生存期（FPS）和总体生存期（OS）较短的独立影响因素（P<0.05）。与低表达组相比，高表达组胶质瘤病人的PFS和OS明显较短（P<0.05）。结论 STRAP高表达与胶质瘤病人不良生存预后有关，这提示其可能成为胶质瘤的分子标志物
Abstract:
Objective To explore the changes of expression of serine-threonine kinase receptor associated protein (STRAP) in human glioma tissues and its clinical significance. Methods The expression levels of STRAP were detected by immunohistochemistry in glioma tissues which were obtained from 160 patients with glioma underwent surgery from June 2013 to September 2016 and in normal brain tissues obtained from 40 patients with traumatic brain injury underwent decompression from June 2018 to March 2019. The follow-up period ended in October 2018. The multivariate Cox proportional regression risk model was used to analyze the risk factors for the survival of glioma patients. Results The expression level of STRAP in glioma tissues was significantly higher than that in normal brain tissues (P<0.05), and the expression level of STRAP increased significantly as the WHO grade of glioma increased (P<0.05). The follow-up ranged from 3 to 60 months. During the follow-up period, 48 aptients died and 98 patients relapsed. The OS ranged 3 to 58 months, and the median OS was 43 months (interquartile, 36~51 months). The PFS ranged from 2 to 60 months, and the median PFS was 32 months (interquartile, 18~40 months). Multivariate Cox proportional regression risk model analysis showed that age≥55 years, preoperative KPS score<80 points, WHO grade Ⅲ to Ⅳ, high expression of STRAP were independent influencing factors for the progression-free survival (FPS) and overall survival (OS) of glioma patients (P<0.05). Compared with the glioma patients with low expression of STRAP, the PFS and OS of glioma patients with high expression were significantly shorter (P<0.05). Conclusion The high expression of STRAP is related to the poor survival and prognosis of patients with glioma, which suggests that it may be a molecular marker of glioma

参考文献/References:

[1] Gusyatiner O, Hegi ME. Glioma epigenetics: from subclassi fication to novel treatment options [J]. Semin Cancer Biol, 2018, 51: 50-58.
[2] Kumar R, Saran S. Structure, molecular dynamics simula- tion, and docking studies of Dictyostelium discoideum and human STRAPs [J]. J Cell Biochem, 2018, 119: 7177-7191.
[3] Manoharan R, Seong HA, Ha H. Dual roles of serine-threo- nine kinase receptor-associated protein (STRAP) in redox- sensitive signaling pathways related to cancer development [J]. Oxid Med Cell Longev, 2018, 19: 1-9.
[4] 朱晓伟，郝解贺. GRP在人脑胶质瘤中的表达及意义[J]. 中国临床神经外科杂志，2015，10（3）：161-163.
[5] 张立志，刘　平，吉慧军，等. 全身炎症反应指数对胶质瘤 患者临床预后影响及与IDH1突变的关系[J]. 实用肿瘤 学杂志，2018，32（1）：25-32.
[6] 赵传祥，袁观斗，陈　谦，等. 丝氨酸苏氨酸激酶受体相关 蛋白在肿瘤发生发展中的作用研究进展[J]. 中华实验外 科杂志，2018，35（1）：171-175.
[7] Yuan G, Zhang B, Yang S, et al. Novel role of STRAP in progression and metastasis of colorectal cancer through Wnt/β-catenin signaling [J]. Oncotarget, 2016, 7(13): 16023-16037.
[8] Denysenko T, Annovazzi L, Cassoni P, et al. WNT/β- catenin signaling pathway and downstream modulators in low- and high-grade glioma [J]. Cancer Genomics Proteo- mics, 2015, 13(1): 31-45.
[9] Fei Y, Xiong Y, Shen X, et al. Cathepsin L promotes ioni- zzing radiation-induced U251 glioma cell migration and invasion through regulating the GSK-3beta/CUX1 pathway [J]. Cell Signal, 2018, 44: 62-71.
[10] Li Q, Wu Q, Li Z, et al. LncRNA LINC00319 is associated with tumorigenesis and poor prognosis in glioma [J]. Eur J Pharmacol, 2019, 861: 1-7.

相似文献/References:

[1]常英男　王　策　赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
　CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(08):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛　克　陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许　耿　路俊锋　杨　忠　施建斌　吴秋月　王　烨　庄冬晓　吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
　XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(08):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰　陈银生　赛　克　张湘衡　柯　超　杨群英　牟永告　许海雄　陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
　LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(08):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波　杨宇焦　张　逵　范润金　张　渊　杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
　YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(08):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚　成于思　王　辉　汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
　HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(08):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林　雨　张　恺　李　帅　杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明　徐成仕　王泽芬　曹长军　李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
　DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(08):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生　田道锋　张申起　陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
　PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(08):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯　驰　郭双毅　程龙海　罗　杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
　FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(08):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]

备注/Memo

备注/Memo:
（2020-04-21收稿，2020-05-13修回）
更新日期/Last Update: 2020-08-14